{
    "clinical_study": {
        "@rank": "112717", 
        "arm_group": [
            {
                "arm_group_label": "spontaneous NAVA mode", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Inspiratory pressure support (IPS)", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a multicenter, prospective, randomized, open-label study which compared two\n      ventilation modes: spontaneous NAVA mode and spontaneous breathing with IPS mode (the latter\n      is considered as the reference ventilatory mode) in patients admitted to the ICU for acute\n      respiratory failure and ventilated with an endotracheal tube. NAVA mode allows to minimize\n      patient-ventilator disharmony with acceptable tolerance and to preserve spontaneous\n      ventilation."
        }, 
        "brief_title": "Study Comparing Two Ventilation Modes NAVA (Neurally Adjusted Ventilatory Assist) Mode and Spontaneous Breathing With Inspiratory Pressure Support (IPS) Mode in Consecutive Patients Hospitalized for Acute Respiratory Failure Requiring Mechanical Ventilation With Endotracheal Tube.", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Respiratory Failure", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Respiratory Distress Syndrome, Adult", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient ventilated with endotracheal tube for more than 24 hours\n\n          -  Return for at least 30 minutes to spontaneous ventilation allowing IPS with a level\n             of pressure support <30 cm H2O;\n\n          -  Level of sedation =< 4 on the Ramsay scale in the absence of medical decision to\n             increase the level of sedation;\n\n          -  Fraction of inspired oxygen (FiO 2) =< 50% with a positive end-expiratory pressure\n             (PEEP) =< 8 cm H2O;\n\n          -  Absence of administration of high-dose vasopressor therapy defined by:\n\n               1. norepinephrine > 0.3 mcg / kg / min;\n\n               2. dopamine > 10 mcg / kg / min;\n\n          -  Estimated duration of mechanical ventilation > 48h00\n\n        Exclusion Criteria:\n\n          -  Contraindication to the implementation of the NAVA endotracheal tube, ie any\n             contraindication to the implementation of a gastric tube or to the repositioning of a\n             tube already in place:\n\n               1. Recent gastrointestinal suture ;\n\n               2. Esophageal varices rupture with gastrointestinal bleeding within 4 days prior to\n                  inclusion;\n\n          -  Therapeutic limitation or active treatment discontinuation;\n\n          -  Pregnant women;\n\n          -  Minors;\n\n          -  Protected adults;\n\n          -  Patient already included in the study;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "129", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02018666", 
            "org_study_id": "N\u00b0 2011-001", 
            "secondary_id": "2011-A00559-32"
        }, 
        "intervention": {
            "arm_group_label": [
                "spontaneous NAVA mode", 
                "Inspiratory pressure support (IPS)"
            ], 
            "intervention_name": "NAVA endotracheal tube", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "state": "Alpes Maritimes", 
                        "zip": "06202"
                    }, 
                    "name": "Hopital L'Archet 1"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "state": "Gironde", 
                        "zip": "33076"
                    }, 
                    "name": "Hopital PELLEGRIN"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "state": "Gironde", 
                        "zip": "33604"
                    }, 
                    "name": "Groupe Hospitalier Sud - H\u00f4pital Haut-Leveque - Maison du Haut-Leveque"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "state": "Haute Vienne", 
                        "zip": "87042"
                    }, 
                    "name": "H\u00f4pital Dupuytren"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "state": "Herault", 
                        "zip": "34295"
                    }, 
                    "name": "Hopital Saint-Eloi - CHU MONTPELLIER"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "state": "Ile de France", 
                        "zip": "75651"
                    }, 
                    "name": "H\u00f4pital de la Piti\u00e9 Salpetri\u00e8re"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "state": "Maine Et Loire", 
                        "zip": "49933"
                    }, 
                    "name": "Hopital Larrey- CHU D'ANGERS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "state": "Normandie", 
                        "zip": "14000"
                    }, 
                    "name": "Hopital de la Cote de Nacre - CHU de CAEN"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont Ferrand", 
                        "country": "France", 
                        "state": "Puy de Dome", 
                        "zip": "63100"
                    }, 
                    "name": "Hopital d'Estaing"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "state": "Rhone Alpes", 
                        "zip": "69004"
                    }, 
                    "name": "Hopital de la CROIX ROUSSE"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "state": "Rhone Alpes", 
                        "zip": "69495"
                    }, 
                    "name": "Centre Hospitalier Lyon Sud"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "ZEPHYR: Multicenter, Prospective, Randomized, Open-label Study in Consecutive Patients Hospitalized for Acute Respiratory Failure Requiring Mechanical Ventilation With Endotracheal Tube. This Study Compared Two Ventilation Modes: NAVA Mode and Spontaneous Breathing With Inspiratory Pressure Support (the Latter is Considered as the Reference Ventilation Mode).", 
        "other_outcome": [
            {
                "measure": "Number of implementation failure of the NAVA endotracheal tube.", 
                "safety_issue": "Yes", 
                "time_frame": "For each patient, the success or failure of the endotracheal tube implementation will be evaluated, this for the entire duration of the study estimated to  18 months"
            }, 
            {
                "measure": "Number and duration of automatic switch into IPS mode", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording until extubation or D14 maximum"
            }, 
            {
                "measure": "Number of Permanent discontinuation of NAVA ventilation mode", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording during the first 48 hours"
            }, 
            {
                "description": "Tolerance of the device", 
                "measure": "Comfort of the device measured by a visual analog scale.", 
                "safety_issue": "Yes", 
                "time_frame": "At the extubation or at D14 maximum"
            }, 
            {
                "description": "Device movements Endotracheal tube obstruction Lesion of the oral or nasal mucosa", 
                "measure": "Side effects associated with the use of the system", 
                "safety_issue": "Yes", 
                "time_frame": "Continuous for the duration of ICU stay, an expected maximum of 14 days"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The time spent in different modes of spontaneous ventilation (NAVA, IPS) and controlled ventilation (VAC controlled pressure) will be measured. The primary endpoint will be the proportion of patients remaining in spontaneous ventilation after the first 48 hours.", 
            "measure": "Evaluate the benefit of NAVA mode as compared to IPS mode in terms of duration of spontaneous ventilation 48 hours after inclusion.", 
            "safety_issue": "No", 
            "time_frame": "Continuous recording during 48 hours following the intubation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02018666"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Reduction of patient / ventilator disharmony, measured during the first 48 hours with the disharmony index", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording during the first 48 hours"
            }, 
            {
                "description": "Feasibility of the initiation of mechanical ventilation in NAVA mode and feasibility of prolonged mechanical ventilation in NAVA mode", 
                "measure": "Real-time spent in NAVA mode and frequency of returns in a controlled mode (controlled ventilation VAC).", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording during the first 48 hours"
            }, 
            {
                "measure": "Earnings on the \"breathing comfort\"", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording during the first 48 hours"
            }, 
            {
                "description": "Total sleep time; Number of arousals per hour; Duration of stage IV sleep ; Duration of Rapid Eye Movement (REM) sleep.", 
                "measure": "Earnings on sleep architecture", 
                "safety_issue": "No", 
                "time_frame": "Continuous recording during the first 48 hours"
            }, 
            {
                "description": "Adverse events associated with the use of the device.\nIncidence of ventilator-acquired pneumonia.\nDuration of ICU stay.\nDuration of hospital stay.\nMortality in the ICU.\nHospital mortality.", 
                "measure": "Tolerance", 
                "safety_issue": "Yes", 
                "time_frame": "Continuous for the duration of ICU stay, an expected maximum of 14 days"
            }
        ], 
        "source": "Clinact", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Clinact", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}